Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial.

Objectives. To evaluate the efficacy, safety, and quality of life by using 2.5 and mifepristone 5 mg daily doses to treat uterine fibroids over 3 months with a 9-month followup period.

Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial.

Objective: To evaluate the efficacy, safety, and quality of life of 5 mg mifepristone per day compared with a placebo in treating uterine fibroids.

Design: Randomized, double-blind clinical study.

Location: Eusebio Hernández Gynecology and Obstetrics Teaching Hospital, Havana, Cuba.